Figure 2.
A staged approach to selecting duration of anticoagulant therapy based on assessment of risk factors for recurrent venous thromboembolism (VTE).
Abbreviations: DVT, deep-vein thrombosis; PE, pulmonary embolism; VKA, vitamin K antagonist; LMWH, low-molecular-weight heparin.